The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

China blocks GSK from participating in national bulk-buy pharmaceutical program

Mon, 31st Oct 2022 10:49

BEIJING, Oct 31 (Reuters) - China has blocked GSK plc from participating in its national bulk-buy pharmaceutical program from Oct. 31, 2022 to April 29, 2024 due to what it said were recent drug product irregularities, state television CCTV reported on Monday. (Reporting by Beijing newsroom; editing by Philippa Fletcher)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.